Peptide YY
Showing 1 - 25 of 2,271
Severe Obesity, Type 2 Diabetes in Obese Trial in São Paulo (Analyze basal expression incretin for immunolabeling and mRNA
Recruiting
- Severe Obesity
- Type 2 Diabetes Mellitus in Obese
- Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Jul 7, 2022
Eating Disorder, Bulimia Nervosa Trial (Acipimox, Placebo)
Enrolling by invitation
- Eating Disorder
- Bulimia Nervosa
- Acipimox
- Placebo
- (no location specified)
Jul 19, 2022
Glycemic Response Trial in Ajman (Food (rice))
Recruiting
- Glycemic Response
- Food (rice)
-
Ajman, United Arab EmiratesRashid Centre for Diabetes and Research
Oct 24, 2022
Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone
Active, not recruiting
- Obesity
-
Nottingham, Notts, United KingdomQueens Medical Centre
Apr 5, 2022
Prader-Willi Syndrome, Hyperphagia Trial in Bronx (Intranasal Oxytocin (IN-OXT), Matched Placebo)
Recruiting
- Prader-Willi Syndrome
- Hyperphagia
- Intranasal Oxytocin (IN-OXT)
- Matched Placebo
-
Bronx, New YorkMontefiore Medical Center, Albert Einstein College of Medicine
Feb 16, 2022
Type 2 Diabetes Trial in Hellerup (Sevelamer, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Sevelamer
- Placebo
-
Hellerup, DenmarkSteno Diabetes Center Copenhagen, Gentofte Hospital
Oct 12, 2021
Feeding and Eating Disorders Trial in Athens (Test meal description changed)
Recruiting
- Feeding and Eating Disorders
- Test meal description changed
-
Athens, OhioOhio University
Jan 26, 2023
Chronic Inflammation, Overweight Trial in Kannapolis (Placebo, Palmitoleic acid, 500 mg (Dose 1), Palmitoleic acid, 1,000 mg
Recruiting
- Chronic Inflammation
- Overweight
- Placebo
- +2 more
-
Kannapolis, North CarolinaUniversity of North Carolina Nutrition Research Institute
Sep 29, 2021
Obesity, Weight Loss Trial in Birmingham (Empagliflozin Arm, Control Arm, Exercise capacity VO2 maximum determination)
Not yet recruiting
- Obesity
- Weight Loss
- Empagliflozin Arm
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
May 22, 2023
Appetitive Behavior Trial (High protein ramen, Standard ramen)
Not yet recruiting
- Appetitive Behavior
- High protein ramen
- Standard ramen
- (no location specified)
Feb 3, 2023
Healthy Trial in Glasgow (Bouts of Exercise)
Not yet recruiting
- Healthy
- Bouts of Exercise
-
Glasgow, United KingdomNew Lister Building at Glasgow Royal Infirmary
Oct 19, 2023
Digestive Health, Gastrointestinal Health, Appetitive Behavior Trial in Montréal (OPTIZIOME® P³ HYDROLYZER® - WHEY, Placebo)
Not yet recruiting
- Digestive Health
- +2 more
- OPTIZIOME® P³ HYDROLYZER® - WHEY
- Placebo
-
Montréal, Quebec, CanadaMcGill University, Currie Gymnasium (Exercise Metabolism and Nut
Jul 21, 2023
Shift Work Type Circadian Rhythm Sleep Disorder Trial in Uberlândia (With Meal during night work, Without Meal during night
Completed
- Shift Work Type Circadian Rhythm Sleep Disorder
- With Meal during night work
- +2 more
-
Uberlândia, Minas Gerais, BrazilCibele Aparecida Crispim
Feb 10, 2022
Overweight, Healthy Trial in Hellerup (Low dose, Placebo, High dose)
Recruiting
- Overweight
- Healthy
- Low dose
- +2 more
-
Hellerup, DenmarkGentofte Hospital
Jul 2, 2022
Obesity Trial (Endobariatric procedure)
Not yet recruiting
- Obesity
- Endobariatric procedure
- (no location specified)
Aug 22, 2022
Overweight and Obesity, Type 2 Diabetes Trial in Chicago (Water, Glucose, Steviol Glycosides)
Enrolling by invitation
- Overweight and Obesity
- Type 2 Diabetes Mellitus
- Water
- +4 more
-
Naples, Florida
- +1 more
Dec 9, 2022
Healthy Trial in Lisboa (Fruit juice)
Completed
- Healthy
- Fruit juice
-
Lisboa, PortugalNOVA Medical School|Faculdade de Ciências Médicas, Universidade
Apr 28, 2023
Appetite Trial in Baton Rouge (Egg Breakfast, Bagel Breakfast)
Completed
- Appetite
- Egg Breakfast
- Bagel Breakfast
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 13, 2022
Metabolic Disturbance, Obesity Trial in Nottingham (Regular meal pattern, Irregular meal pattern)
Completed
- Metabolic Disturbance
- Obesity
- Regular meal pattern
- Irregular meal pattern
-
Nottingham, Nottinghamshire, United KingdomThe University of Nottingham
Nov 1, 2022
Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))
Not yet recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular Denervation System (Netrod)
- (no location specified)
Jan 5, 2023
Type 2 Diabetes Trial in Odense (Low carbohydrate)
Recruiting
- Type 2 Diabetes
- Low carbohydrate
-
Odense, DenmarkOdense University Hospital
Aug 10, 2022
Hunger Trial (Huel Powder)
Not yet recruiting
- Hunger
- Huel Powder
- (no location specified)
Sep 24, 2023
Eating Behavior, Overweight, Obesity Trial in Davis (Almond snack, Cereal-based snack)
Terminated
- Eating Behavior
- +2 more
- Almond snack
- Cereal-based snack
-
Davis, CaliforniaUSDA, ARS, Western Human Nutrition Research Center
Aug 8, 2022